Further study also revealed that the overexpression of STC2 predicted poor prognosis in nasopharyngeal carcinoma [20], laryngeal squamous carcinoma [21], and hepatocellular carcinoma [22]. The gene discussed is STC2; the disease is hepatocellular carcinoma.